PubRank
Search
About
Laura Orsatti
Author PubWeight™ 14.02
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Mechanism of action and antiviral activity of benzimidazole-based allosteric inhibitors of the hepatitis C virus RNA-dependent RNA polymerase.
J Virol
2003
2.63
2
Characterization of the inhibition of hepatitis C virus RNA replication by nonnucleosides.
J Virol
2004
1.71
3
Structural and biochemical characterization of the wild type PCSK9-EGF(AB) complex and natural familial hypercholesterolemia mutants.
J Biol Chem
2008
1.41
4
PP2A regulates HDAC4 nuclear import.
Mol Biol Cell
2007
1.34
5
A proprotein convertase subtilisin-like/kexin type 9 (PCSK9) C-terminal domain antibody antigen-binding fragment inhibits PCSK9 internalization and restores low density lipoprotein uptake.
J Biol Chem
2010
1.32
6
Hepatitis C virus NS5A is a direct substrate of casein kinase I-alpha, a cellular kinase identified by inhibitor affinity chromatography using specific NS5A hyperphosphorylation inhibitors.
J Biol Chem
2006
1.30
7
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor.
Blood
2006
1.04
8
Generation and selection of novel fully human monoclonal antibodies that neutralize Dickkopf-1 (DKK1) inhibitory function in vitro and increase bone mass in vivo.
J Biol Chem
2010
1.04
9
Ezrin is a specific and direct target of protein tyrosine phosphatase PRL-3.
Biochim Biophys Acta
2007
0.96
10
Differential screening of phage-ab libraries by oligonucleotide microarray technology.
PLoS One
2008
0.84
11
An efficient and versatile synthesis of bisPNA-peptide conjugates based on chemoselective oxime formation.
Bioconjug Chem
2003
0.76